General MedicationsTOPICALGeneric
HALOG
HALCINONIDE
Standard Dose
0.025%
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview HALOG is listed in Drugs@FDA under application 018125 (NDA).
Marketing status: Discontinued Active ingredient HALCINONIDE Form and strength OINTMENT;TOPICAL - 0.025% Sponsor BRISTOL MYERS SQUIBB Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview HALOG is listed in Drugs@FDA under application 018125 (NDA). Marketing status: Discontinued Active ingredient HALCINONIDE Form and strength OINTMENT;TOPICAL - 0.025% Sponsor BRISTOL MYERS SQUIBB Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.